About this trial
The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are:
* Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated? * Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation?
Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol.
Participants will:
* Drink one protein beverage every day for 6 weeks; * Go to a LabCorp facility for a blood draw before and after the 6 weeks.
Eligibility criteria
Qualifiers
Cholesterol reading of 190 to 225 mg/dL
Age 21-59 years old
Disqualifiers
Uncontrolled diabetes
Hypothyroidism or other hormonal problems that have not stabilized
Any liver diseases being actively treated
Cancer
Trial design
Treatments tested in this trial
- Standard whey
- Hydrolyzed whey
Treatment groups
Sponsors and collaborators
Medinutra LLC
Lead sponsor
Dairy Management Inc.
Collaborator